Resource Library
|
|
|
|||||||||
|
Powered by:
This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product.
Ischemic cardiomyopathyDefinitionIschemic cardiomyopathy is a term that doctors use to describe patients who have congestive heart failure due to coronary artery disease. "Ischemic" means that an organ (such as the heart) is not getting enough blood and oxygen. "Cardio" means heart and "myopathy" means muscle-related disease. See also: Alternative NamesIschemic heart disease; Cardiomyopathy - ischemic CausesIschemic cardiomyopathy results when the arteries that bring blood and oxygen to the heart are blocked. There may be a buildup of cholesterol and other substances, called plaque, in the arteries that bring oxygen to heart muscle tissue. Over time, the heart muscle does not work well, and it is more difficult for the heart to fill and release blood. Ischemic cardiomyopathy is a common cause of congestive heart failure. Patients with this condition may at one time have had a heart attack, angina, or unstable angina. A few patients may not have noticed any previous symptoms. Ischemic cardiomyopathy is the most common type of cardiomyopathy in the United States. It affects approximately 1 out of 100 people, most often middle-aged to elderly men. Risks for this condition include:
SymptomsPatients with ischemic cardiomyopathy usually have symptoms of angina and heart failure. Symptoms of angina include:
Symptoms of heart failure usually develop slowly over time. However, sometimes symptoms start very suddenly and are severe. Common symptoms include:
Exams and TestsThe physical examination may be normal, or it may reveal signs of fluid buildup:
There may be other signs of heart failure. This condition is usually diagnosed only if a test shows that the pumping function of the heart is too low. This is called a decreased ejection fraction. A normal ejection fraction is around 55 - 65%. Most patients with this disorder have ejection fractions much less than this. Tests used to measure ejection fraction include:
Biopsy of the heart is needed in rare cases to rule out other disorders. Lab tests that may be used to rule out other disorders and assess the condition of the heart include:
TreatmentThis version of the Encyclopedia has no treatment information. Please discuss any and all treatment options for your condition with your healthcare professional. Outlook (Prognosis)This is a very serious disorder. It is a chronic illness that usually gets worse over time. Infection and other stress on your body from other medical illnesses will also cause symptoms to get worse. It is very important to discuss your situation with your doctor to ensure that you can improve it as much as possible. You can control symptoms of heart failure and angina with medication, lifestyle changes, and by treating any underlying disorder. Possible Complications
When to Contact a Medical ProfessionalGo to the emergency room or call 911 if:
PreventionThe best way to prevent ischemic cardiomyopathy is to avoid getting heart disease.
ReferencesHunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guidelines Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442. Hare JM. The dilated, restrictive, and infiltrative cardiomyopathies. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa; Saunders Elsevier;2007:chap 64.
Review Date:
4/23/2009 Reviewed By: Alan Berger, MD, Assistant Profesor, Division of Cardiology and Epidemiology, University of Minnesota, Minneapolis, MN. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
|
||||||||||








